{"entity":{"type":"insider","cik":"0001257241","url":"/insider/0001257241","json_url":"/insider/0001257241.json","name":"DURUS CAPITAL MANAGEMENT NA LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":1473,"n_filings":50,"first":"2003-07-31","last":"2003-07-31","span_basis":"filed_date"},"name_variants":[{"name":"DURUS CAPITAL MANAGEMENT NA LLC","source":"filing","n_filings":50,"first_seen":"2003-07-31","last_seen":"2003-07-31"}],"transactions":[{"id":82159,"accession":"0001005477-03-002897","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001005477-03-002897","line_url":"/filing/0001005477-03-002897","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11400.0,"shares_display":"11,400","price_per_share":15.759728947368421,"price_display":"15.76","price_state":"stated","total_value":179660.91,"total_display":"179,660.91","total_whole":"179,661","shares_owned_after":21551864.0,"shares_owned_after_display":"21,551,864","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-24","filed_date":"2003-07-31","scope":"insider","n_lines":2},{"id":82157,"accession":"0001005477-03-002897","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001005477-03-002897","line_url":"/filing/0001005477-03-002897","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":252100.0,"shares_display":"252,100","price_per_share":15.0586178500595,"price_display":"15.06","price_state":"stated","total_value":3796277.56,"total_display":"3,796,277.56","total_whole":"3,796,278","shares_owned_after":21447464.0,"shares_owned_after_display":"21,447,464","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-24","filed_date":"2003-07-31","scope":"insider","n_lines":2},{"id":33283,"accession":"0001005477-03-002860","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001005477-03-002860","line_url":"/filing/0001005477-03-002860#line-21","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT NA LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43078.0,"shares_display":"43,078","price_per_share":19.6864,"price_display":"19.69","price_state":"stated","total_value":848050.7392,"total_display":"848,050.74","total_whole":"848,051","shares_owned_after":9726900.0,"shares_owned_after_display":"9,726,900","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-24","filed_date":"2003-07-31","scope":"insider"},{"id":82155,"accession":"0001005477-03-002897","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001005477-03-002897","line_url":"/filing/0001005477-03-002897#line-8","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79700.0,"shares_display":"79,700","price_per_share":15.62,"price_display":"15.62","price_state":"stated","total_value":1244914.0,"total_display":"1,244,914.00","total_whole":"1,244,914","shares_owned_after":21309064.0,"shares_owned_after_display":"21,309,064","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-23","filed_date":"2003-07-31","scope":"insider"},{"id":82154,"accession":"0001005477-03-002897","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001005477-03-002897","line_url":"/filing/0001005477-03-002897#line-7","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31800.0,"shares_display":"31,800","price_per_share":15.56,"price_display":"15.56","price_state":"stated","total_value":494808.0,"total_display":"494,808.00","total_whole":"494,808","shares_owned_after":21388764.0,"shares_owned_after_display":"21,388,764","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-23","filed_date":"2003-07-31","scope":"insider"},{"id":33282,"accession":"0001005477-03-002860","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001005477-03-002860","line_url":"/filing/0001005477-03-002860","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT NA LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":158600.0,"shares_display":"158,600","price_per_share":19.379598108448928,"price_display":"19.38","price_state":"stated","total_value":3073604.26,"total_display":"3,073,604.26","total_whole":"3,073,604","shares_owned_after":9769978.0,"shares_owned_after_display":"9,769,978","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-23","filed_date":"2003-07-31","scope":"insider","n_lines":3},{"id":33279,"accession":"0001005477-03-002860","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001005477-03-002860","line_url":"/filing/0001005477-03-002860#line-17","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT NA LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7300.0,"shares_display":"7,300","price_per_share":19.429,"price_display":"19.43","price_state":"stated","total_value":141831.7,"total_display":"141,831.70","total_whole":"141,832","shares_owned_after":9928578.0,"shares_owned_after_display":"9,928,578","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-23","filed_date":"2003-07-31","scope":"insider"},{"id":82153,"accession":"0001005477-03-002897","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001005477-03-002897","line_url":"/filing/0001005477-03-002897#line-6","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25885.0,"shares_display":"25,885","price_per_share":15.2673,"price_display":"15.27","price_state":"stated","total_value":395194.0605,"total_display":"395,194.06","total_whole":"395,194","shares_owned_after":21356964.0,"shares_owned_after_display":"21,356,964","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-22","filed_date":"2003-07-31","scope":"insider"},{"id":82152,"accession":"0001005477-03-002897","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001005477-03-002897","line_url":"/filing/0001005477-03-002897","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68600.0,"shares_display":"68,600","price_per_share":15.2009,"price_display":"15.20","price_state":"stated","total_value":1042781.74,"total_display":"1,042,781.74","total_whole":"1,042,782","shares_owned_after":21371849.0,"shares_owned_after_display":"21,371,849","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-22","filed_date":"2003-07-31","scope":"insider","n_lines":2},{"id":43208,"accession":"0001005477-03-002836","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001005477-03-002836","line_url":"/filing/0001005477-03-002836#line-30","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; DURUS CAPITAL MANAGEMENT NA LLC; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":4.9,"price_display":"4.90","price_state":"stated","total_value":36750.0,"total_display":"36,750.00","total_whole":"36,750","shares_owned_after":3357300.0,"shares_owned_after_display":"3,357,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-22","filed_date":"2003-07-31","scope":"insider"},{"id":33278,"accession":"0001005477-03-002860","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001005477-03-002860","line_url":"/filing/0001005477-03-002860","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT NA LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":99600.0,"shares_display":"99,600","price_per_share":19.15062108433735,"price_display":"19.15","price_state":"stated","total_value":1907401.86,"total_display":"1,907,401.86","total_whole":"1,907,402","shares_owned_after":9921278.0,"shares_owned_after_display":"9,921,278","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-22","filed_date":"2003-07-31","scope":"insider","n_lines":2},{"id":33276,"accession":"0001005477-03-002860","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001005477-03-002860","line_url":"/filing/0001005477-03-002860#line-14","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT NA LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1700.0,"shares_display":"1,700","price_per_share":19.015,"price_display":"19.02","price_state":"stated","total_value":32325.5,"total_display":"32,325.50","total_whole":"32,326","shares_owned_after":10020878.0,"shares_owned_after_display":"10,020,878","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-22","filed_date":"2003-07-31","scope":"insider"},{"id":82150,"accession":"0001005477-03-002897","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001005477-03-002897","line_url":"/filing/0001005477-03-002897#line-3","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20500.0,"shares_display":"20,500","price_per_share":15.0008,"price_display":"15.00","price_state":"stated","total_value":307516.4,"total_display":"307,516.40","total_whole":"307,516","shares_owned_after":21314249.0,"shares_owned_after_display":"21,314,249","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-21","filed_date":"2003-07-31","scope":"insider"},{"id":82149,"accession":"0001005477-03-002897","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005477-03-002897","line_url":"/filing/0001005477-03-002897","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":192900.0,"shares_display":"192,900","price_per_share":15.0065,"price_display":"15.01","price_state":"stated","total_value":2894753.85,"total_display":"2,894,753.85","total_whole":"2,894,754","shares_owned_after":21304749.0,"shares_owned_after_display":"21,304,749","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-21","filed_date":"2003-07-31","scope":"insider","n_lines":2},{"id":33275,"accession":"0001005477-03-002860","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001005477-03-002860","line_url":"/filing/0001005477-03-002860","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT NA LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":44900.0,"shares_display":"44,900","price_per_share":19.362086636971046,"price_display":"19.36","price_state":"stated","total_value":869357.69,"total_display":"869,357.69","total_whole":"869,358","shares_owned_after":10020478.0,"shares_owned_after_display":"10,020,478","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-21","filed_date":"2003-07-31","scope":"insider","n_lines":3},{"id":33272,"accession":"0001005477-03-002860","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001005477-03-002860","line_url":"/filing/0001005477-03-002860","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT NA LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":72900.0,"shares_display":"72,900","price_per_share":19.1335,"price_display":"19.13","price_state":"stated","total_value":1394832.15,"total_display":"1,394,832.15","total_whole":"1,394,832","shares_owned_after":10053078.0,"shares_owned_after_display":"10,053,078","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-21","filed_date":"2003-07-31","scope":"insider","n_lines":2},{"id":33313,"accession":"0001005477-03-002896","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001005477-03-002896","line_url":"/filing/0001005477-03-002896#line-30","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35500.0,"shares_display":"35,500","price_per_share":14.4292,"price_display":"14.43","price_state":"stated","total_value":512236.6,"total_display":"512,236.60","total_whole":"512,237","shares_owned_after":21141849.0,"shares_owned_after_display":"21,141,849","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-18","filed_date":"2003-07-31","scope":"insider"},{"id":33312,"accession":"0001005477-03-002896","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001005477-03-002896","line_url":"/filing/0001005477-03-002896#line-29","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65500.0,"shares_display":"65,500","price_per_share":14.1433,"price_display":"14.14","price_state":"stated","total_value":926386.15,"total_display":"926,386.15","total_whole":"926,386","shares_owned_after":21177349.0,"shares_owned_after_display":"21,177,349","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-18","filed_date":"2003-07-31","scope":"insider"},{"id":33270,"accession":"0001005477-03-002860","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001005477-03-002860","line_url":"/filing/0001005477-03-002860","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT NA LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41900.0,"shares_display":"41,900","price_per_share":19.64826324582339,"price_display":"19.65","price_state":"stated","total_value":823262.23,"total_display":"823,262.23","total_whole":"823,262","shares_owned_after":9991678.0,"shares_owned_after_display":"9,991,678","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-18","filed_date":"2003-07-31","scope":"insider","n_lines":2},{"id":33268,"accession":"0001005477-03-002860","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001005477-03-002860","line_url":"/filing/0001005477-03-002860#line-6","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT NA LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17300.0,"shares_display":"17,300","price_per_share":19.6312,"price_display":"19.63","price_state":"stated","total_value":339619.76,"total_display":"339,619.76","total_whole":"339,620","shares_owned_after":10033078.0,"shares_owned_after_display":"10,033,078","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-18","filed_date":"2003-07-31","scope":"insider"},{"id":33311,"accession":"0001005477-03-002896","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001005477-03-002896","line_url":"/filing/0001005477-03-002896","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13452.0,"shares_display":"13,452","price_per_share":13.892573862622658,"price_display":"13.89","price_state":"stated","total_value":186882.9036,"total_display":"186,882.90","total_whole":"186,883","shares_owned_after":21113001.0,"shares_owned_after_display":"21,113,001","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-17","filed_date":"2003-07-31","scope":"insider","n_lines":2},{"id":33309,"accession":"0001005477-03-002896","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001005477-03-002896","line_url":"/filing/0001005477-03-002896","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":117200.0,"shares_display":"117,200","price_per_share":13.9544,"price_display":"13.95","price_state":"stated","total_value":1635455.68,"total_display":"1,635,455.68","total_whole":"1,635,456","shares_owned_after":21107801.0,"shares_owned_after_display":"21,107,801","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-17","filed_date":"2003-07-31","scope":"insider","n_lines":2},{"id":33267,"accession":"0001005477-03-002860","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001005477-03-002860","line_url":"/filing/0001005477-03-002860#line-5","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT NA LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14500.0,"shares_display":"14,500","price_per_share":19.6731,"price_display":"19.67","price_state":"stated","total_value":285259.95,"total_display":"285,259.95","total_whole":"285,260","shares_owned_after":10015778.0,"shares_owned_after_display":"10,015,778","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-17","filed_date":"2003-07-31","scope":"insider"},{"id":33266,"accession":"0001005477-03-002860","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001005477-03-002860","line_url":"/filing/0001005477-03-002860","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT NA LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":85500.0,"shares_display":"85,500","price_per_share":19.7541,"price_display":"19.75","price_state":"stated","total_value":1688975.55,"total_display":"1,688,975.55","total_whole":"1,688,976","shares_owned_after":10017278.0,"shares_owned_after_display":"10,017,278","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-17","filed_date":"2003-07-31","scope":"insider","n_lines":2},{"id":95117,"accession":"0001005477-03-002859","txn_seq":30,"anchor":"line-30","filing_url":"/filing/0001005477-03-002859","line_url":"/filing/0001005477-03-002859#line-30","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT","owner_display_name":"SACANE SCOTT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":46900.0,"shares_display":"46,900","price_per_share":19.8936,"price_display":"19.89","price_state":"stated","total_value":933009.84,"total_display":"933,009.84","total_whole":"933,010","shares_owned_after":10089078.0,"shares_owned_after_display":"10,089,078","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-16","filed_date":"2003-07-31","scope":"insider"},{"id":43207,"accession":"0001005477-03-002836","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001005477-03-002836","line_url":"/filing/0001005477-03-002836#line-29","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; DURUS CAPITAL MANAGEMENT NA LLC; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3700.0,"shares_display":"3,700","price_per_share":4.91,"price_display":"4.91","price_state":"stated","total_value":18167.0,"total_display":"18,167.00","total_whole":"18,167","shares_owned_after":3286000.0,"shares_owned_after_display":"3,286,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-16","filed_date":"2003-07-31","scope":"insider"},{"id":33307,"accession":"0001005477-03-002896","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001005477-03-002896","line_url":"/filing/0001005477-03-002896#line-24","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17675.0,"shares_display":"17,675","price_per_share":13.9516,"price_display":"13.95","price_state":"stated","total_value":246594.53,"total_display":"246,594.53","total_whole":"246,595","shares_owned_after":21008101.0,"shares_owned_after_display":"21,008,101","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-16","filed_date":"2003-07-31","scope":"insider"},{"id":33306,"accession":"0001005477-03-002896","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001005477-03-002896","line_url":"/filing/0001005477-03-002896","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":161000.0,"shares_display":"161,000","price_per_share":13.873037888198757,"price_display":"13.87","price_state":"stated","total_value":2233559.1,"total_display":"2,233,559.10","total_whole":"2,233,559","shares_owned_after":21000776.0,"shares_owned_after_display":"21,000,776","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-16","filed_date":"2003-07-31","scope":"insider","n_lines":3},{"id":33264,"accession":"0001005477-03-002860","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001005477-03-002860","line_url":"/filing/0001005477-03-002860","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT; SACANE SCOTT","owner_display_name":"DURUS CAPITAL MANAGEMENT NA LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":144300.0,"shares_display":"144,300","price_per_share":19.886137837837836,"price_display":"19.89","price_state":"stated","total_value":2869569.69,"total_display":"2,869,569.69","total_whole":"2,869,570","shares_owned_after":9961178.0,"shares_owned_after_display":"9,961,178","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-16","filed_date":"2003-07-31","scope":"insider","n_lines":2},{"id":95116,"accession":"0001005477-03-002859","txn_seq":29,"anchor":"line-29","filing_url":"/filing/0001005477-03-002859","line_url":"/filing/0001005477-03-002859#line-29","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT","owner_display_name":"SACANE SCOTT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":67000.0,"shares_display":"67,000","price_per_share":19.9401,"price_display":"19.94","price_state":"stated","total_value":1335986.7,"total_display":"1,335,986.70","total_whole":"1,335,987","shares_owned_after":10042178.0,"shares_owned_after_display":"10,042,178","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-15","filed_date":"2003-07-31","scope":"insider"},{"id":95115,"accession":"0001005477-03-002859","txn_seq":28,"anchor":"line-28","filing_url":"/filing/0001005477-03-002859","line_url":"/filing/0001005477-03-002859#line-28","is_derivative":false,"issuer_cik":"0001066745","issuer_name":"ESPERION THERAPEUTICS INC/MI","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001066745","owner_cik":null,"owner_name":"SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC; DURUS CAPITAL MANAGEMENT","owner_display_name":"SACANE SCOTT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23300.0,"shares_display":"23,300","price_per_share":19.9324,"price_display":"19.93","price_state":"stated","total_value":464424.92,"total_display":"464,424.92","total_whole":"464,425","shares_owned_after":10109178.0,"shares_owned_after_display":"10,109,178","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-15","filed_date":"2003-07-31","scope":"insider"},{"id":33303,"accession":"0001005477-03-002896","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001005477-03-002896","line_url":"/filing/0001005477-03-002896","is_derivative":false,"issuer_cik":"0000902600","issuer_name":"AKSYS LTD","issuer_ticker":"AKSY","issuer_name_source":null,"issuer_url":"/issuer/0000902600","owner_cik":null,"owner_name":"DURUS CAPITAL MANAGEMENT; SACANE SCOTT; DURUS CAPITAL MANAGEMENT NA LLC","owner_display_name":"DURUS CAPITAL MANAGEMENT","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54200.0,"shares_display":"54,200","price_per_share":13.85403450184502,"price_display":"13.85","price_state":"stated","total_value":750888.67,"total_display":"750,888.67","total_whole":"750,889","shares_owned_after":20866276.0,"shares_owned_after_display":"20,866,276","ownership_form":"I","is_10b5_1":null,"transaction_date":"2003-07-15","filed_date":"2003-07-31","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":"2003-07-15|33302","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000902600","name":"AKSYS LTD","url":"/issuer/0000902600","role":"Ten percent owner","n_filings":26,"first_seen":"2003-07-31","last_seen":"2003-07-31"},{"type":"issuer","type_label":"ISSUER","cik":"0001066745","name":"ESPERION THERAPEUTICS INC/MI","url":"/issuer/0001066745","role":"Ten percent owner","n_filings":24,"first_seen":"2003-07-31","last_seen":"2003-07-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001257241","retrieved_at":"2026-08-25T19:42:08+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}